The initiation of coverage by Piper Sandler with an Overweight rating and a high price target suggests a strong positive sentiment towards Abivax's stock. This is likely to influence investor perception positively in the short term, potentially leading to an increase in stock price as market participants react to the analyst's bullish outlook.